Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT01606488
PHASE4

Effects of Brain Beta-Amyloid on Postoperative Cognition

Sponsor: University of California, San Francisco

View on ClinicalTrials.gov

Summary

Postoperative cognitive decline (POCD) affects up to 50% of non-cardiac surgical patients greater than or equal to 65 years of age. This study will test the hypothesis that preoperative presence of brain beta-amyloid plaques in non-demented subjects increases postoperative cognitive decline (POCD) in elderly subjects scheduled for hip or knee replacement. The investigators hypothesize that preoperative beta-amyloid plaques will predict postoperative cognitive decline.

Official title: Effects of Brain Beta Amyloid on Postoperative Cognition and 18F-AV-45-A14: Clinical Evaluation of Florbetapir F 18 (18F-AV-45)

Key Details

Gender

All

Age Range

65 Years - Any

Study Type

INTERVENTIONAL

Enrollment

66

Start Date

2012-05

Completion Date

2026-06

Last Updated

2025-05-01

Healthy Volunteers

No

Interventions

DRUG

Florbetapir F 18 (18F-AV-45)

Single IV bolus injection of 370 MBq (10mCi) florbetapir will be administered approximately 50 minutes prior to a 10 minute PET scan.

OTHER

no intervention

Locations (1)

San Francisco VA Medical Center

San Francisco, California, United States